DiaMedica Therapeutics Inc. (DMAC)

NASDAQ: DMAC · IEX Real-Time Price · USD

2.800

-0.150 (-5.08%)

At close: Jul 2, 2024, 4:00 PM

2.801

+0.001 (0.04%)

After-hours: Jul 2, 2024, 7:38 PM EDT

DiaMedica Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2016
Net Income	-19.3	-13.7	-13.64	-12.3	-10.65	Upgrade
Depreciation & Amortization	0.1	0.09	0.08	0.07	0.07	Upgrade
Share-Based Compensation	1.68	1.5	1.56	1.84	1.16	Upgrade
Other Operating Activities	-1.21	0.6	-0.25	1.2	0.31	Upgrade
Operating Cash Flow	-18.73	-11.51	-12.25	-9.19	-9.1	Upgrade
Capital Expenditures	-0.02	-0.08	-0.02	-0.03	0.01	Upgrade
Change in Investments	-18.28	11.62	-20.52	-16.1	-3.92	Upgrade
Investing Cash Flow	-18.3	11.54	-20.54	-16.13	-3.91	Upgrade
Share Issuance / Repurchase	36.85	0	30.09	28.85	0.08	Upgrade
Debt Issued / Paid	-0.01	-0.01	-0.01	-0.01	-0.01	Upgrade
Financing Cash Flow	36.84	-0.01	30.09	28.85	0.07	Upgrade
Net Cash Flow	-0.19	0.02	-2.7	3.53	-12.94	Upgrade
Free Cash Flow	-18.75	-11.59	-12.27	-9.22	-9.09	Upgrade
Free Cash Flow Per Share	-0.58	-0.44	-0.59	-0.59	-0.76	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).